李莎莎, 李琴, 李翊铭, 商悦, 何红伟, 陈淑珍, 舒积成, 甘茂罗. 海洋来源链霉菌IMB18-531与枝孢菌IMB19-099共培养代谢产物研究J. 药学学报, 2023, 58(4): 967-974. DOI: 10.16438/j.0513-4870.2022-1130
引用本文: 李莎莎, 李琴, 李翊铭, 商悦, 何红伟, 陈淑珍, 舒积成, 甘茂罗. 海洋来源链霉菌IMB18-531与枝孢菌IMB19-099共培养代谢产物研究J. 药学学报, 2023, 58(4): 967-974. DOI: 10.16438/j.0513-4870.2022-1130
LI Sha-sha, LI Qin, LI Yi-ming, SHANG Yue, HE Hong-wei, CHEN Shu-zhen, SHU Ji-cheng, GAN Mao-luo. Identification of the metabolites from co-cultures of marine Streptomyces sp. IMB18-531 and Cladosporium sp. IMB19-099J. Acta Pharmaceutica Sinica, 2023, 58(4): 967-974. DOI: 10.16438/j.0513-4870.2022-1130
Citation: LI Sha-sha, LI Qin, LI Yi-ming, SHANG Yue, HE Hong-wei, CHEN Shu-zhen, SHU Ji-cheng, GAN Mao-luo. Identification of the metabolites from co-cultures of marine Streptomyces sp. IMB18-531 and Cladosporium sp. IMB19-099J. Acta Pharmaceutica Sinica, 2023, 58(4): 967-974. DOI: 10.16438/j.0513-4870.2022-1130

海洋来源链霉菌IMB18-531与枝孢菌IMB19-099共培养代谢产物研究

Identification of the metabolites from co-cultures of marine Streptomyces sp. IMB18-531 and Cladosporium sp. IMB19-099

  • 摘要: 利用中压反相色谱、凝胶柱色谱和HPLC等多种色谱分离方法对两株海洋来源微生物——链霉菌IMB18-531与枝孢菌IMB19-099的共培养发酵物进行分离纯化, 共分离得到9个化合物。根据波谱学数据分析并结合化学方法, 分别鉴定为: 铝草氨菌素E (1)、去铁胺E (2)、铁草氨菌素E (3)、terragine E (4)、卡巴西霉素(5)、环(L-脯氨酰-L-酪氨酸) (6)、邻氨基苯甲酸(7)、(Z)-14-甲基十五烷-9-烯酸(8) 和(Z)-十六烷-8-烯酸(9)。其中, 化合物1为新化合物。活性筛选结果表明, 化合物2显示出抗肝纤维化活性, 能够抑制肝纤维化相关基因COL1A1MMP2TIMP2的表达。化合物589对甲氧西林耐药金葡菌、表皮葡萄球菌、枯草芽孢杆菌显出抗菌活性, MIC为16~64 μg·mL-1。化合物5对人胰腺癌细胞MIA Paca-2和结肠癌细胞HT-29显示出显著的细胞毒活性, IC50分别为2.9和6.3 μmol·L-1

     

    Abstract: A new siderophore chelate (1) and 8 known compounds were identified from the liquid co-cultures of the marine-derived Streptomyces sp. IMB18-531 and Cladosporium sp. IMB19-099 by a combination of chromatography methods, including C18 reversed-phase medium pressure chromatography, gel column chromatography and HPLC. Their structures were determined by spectroscopic analysis and chemical methods as aluminioxamine E (1), desferrioxamine E (2), ferrioxamine E (3), terragine E (4), capsimicin (5), cyclo(L-prolinyl-L-tyrosine) (6), anthranilic acid (7), (Z)-14-methylpentadec-9-enoic acid (8), and (Z)-hexadec-8-enoic acid (9). Compound 2 showed inhibitory activities against the expression of liver fibrosis related genes COL1A1, MMP2, and TIMP2. Compounds 5, 8, and 9 displayed antibacterial activities against methicillin-resistant Staphylococcus aureus, S. epidermidis and Bacillus subtilis, with MICs of 16-64 μg·mL-1. Compound 5 showed cytotoxicities against human pancreatic cancer MIA Paca-2 and human colon cancer HT-29 cell lines with IC50 of 2.9 and 6.3 μmol·L-1, respectively.

     

/

返回文章
返回